Search

everythinglearnresearchcommunity

for

Search:↓

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

New cancer treatments aim to reduce side effects and improve effectiveness.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Baldness may lower the risk of testicular cancer.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ficus carica leaf extract may help treat melanoma by promoting cancer cell death without harming normal cells.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Suppressing very long chain fatty acids is linked to skin cancer.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.